Followers | 240 |
Posts | 12042 |
Boards Moderated | 1 |
Alias Born | 04/05/2009 |
Friday, June 03, 2016 8:57:53 AM
WILMINGTON, Del., June 2, 2016 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC) strongly refutes the report by Citron Research issued today.
Chemours, a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, was created to build on its fundamental strengths.
Upon becoming an independent company less than one year ago, Chemours immediately launched a five-point transformation plan to improve Adjusted EBITDA by $500 million over 2015 levels and reduce its leverage ratio to approximately three times in 2017. Chemours continues to execute on all aspects of its plan by reducing cost, optimizing its portfolio, growing market positions, refocusing investments and enhancing its organization. The company has taken swift and decisive action under this plan and has already delivered significant cost reductions while strengthening its liquidity position. Chemours is making major investments in key growth initiatives, and continues to progress the strategic review of its Chemical Solutions business.
The company reaffirms its 2016 outlook of Adjusted EBITDA above the 2015 performance, generating modestly positive free cash flow. This includes the expectation of $200 million of cost savings realized in 2016.
Information about Chemours businesses, market positions and financial performance is available on Chemours.com.
About The Chemours Company
The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry. Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and oil refining operations and general industrial manufacturing. Our flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™, Viton™, Opteon™ and Nafion™. Chemours has approximately 8,100 employees across 35 manufacturing sites serving more than 5,000 customers in North America, Latin America, Asia-Pacific and Europe. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC. For more information please visit chemours.com or follow Chemours on Twitter at @chemours.
http://www.prnewswire.com/news-releases/chemours-strongly-refutes-citron-report-300279108.html
"Someone said it takes 30 years to be an instant success" - Gabriel Barbier-Mueller, CEO of Harwood International
Recent CC News
- The Gross Law Firm Notifies Shareholders of The Chemours Company(CC) of a Class Action Lawsuit and an Upcoming Deadline • PR Newswire (US) • 04/16/2024 09:50:00 AM
- The Gross Law Firm Notifies Shareholders of The Chemours Company(CC) of a Class Action Lawsuit and an Upcoming Deadline • PR Newswire (US) • 04/12/2024 09:45:00 AM
- Class Action Filed Against The Chemours Company (CC) Seeking Recovery for Investors - Contact The Gross Law Firm • PR Newswire (US) • 04/09/2024 10:00:00 AM
- The Gross Law Firm Reminds The Chemours Company Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2024 - CC • PR Newswire (US) • 04/05/2024 09:45:00 AM
- Chemours Recognized With Two Awards From U.S. Department of Energy’s Better Buildings, Better Plants Initiative • Business Wire • 04/04/2024 10:45:00 AM
- Walgreens Slashes Annual Profit Forecast; MillerKnoll Nosedives 17% on Bleak 4Q Outlook, and Latest News • IH Market News • 03/28/2024 01:48:04 PM
- Chemours Announces Completion of Planned Procedures by the Audit Committee with Respect to Internal Review • Business Wire • 03/27/2024 09:30:00 PM
- The Chemours Company Reports Fourth Quarter and Full Year 2023 Results • Business Wire • 03/27/2024 09:25:00 PM
- CC) AND LEAD PLAINTIFF DEADLINE • PR Newswire (US) • 03/27/2024 12:00:00 PM
- Chemours Announces Dates for Fourth Quarter 2023 Earnings Release, 2023 Form 10-K Filing and Webcast Conference Call • Business Wire • 03/26/2024 08:45:00 PM
- Chemours Announces Appointment of Denise Dignam as President and Chief Executive Officer of the Company • Business Wire • 03/22/2024 08:45:00 PM
- Chemours and Partners Selected for $60M in U.S. Department of Energy Grants to Support Continued Advancement of Global Hydrogen Economy • Business Wire • 03/20/2024 10:45:00 AM
- Chemours Receives NYSE Notice Regarding Delayed Form 10-K Filing • Business Wire • 03/18/2024 09:16:00 PM
- Chemours Provides Update on Internal Review • Business Wire • 03/07/2024 01:30:00 AM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 03/06/2024 10:32:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:08:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:07:52 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:07:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:05:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:04:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:02:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:01:41 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:00:24 AM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 02/29/2024 01:19:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 01:17:55 PM
FEATURED Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • Apr 17, 2024 8:00 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM